H1B Report
Side-by-side comparison

NIVAGEN PHARMACEUTICALS, INC. vs Ernst & Young U.S. LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
NIVAGEN PHARMACEUTICALS, INC.
CARank #FEIN 27-1447740
Entity B
Ernst & Young U.S. LLP
NJRank #5FEIN 34-6565596

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricNIVAGEN PHARMACEUTICALS, INC.Ernst & Young U.S. LLP
Total filings4723,247
Certified %97.87%94.86%
Denied %0.00%0.11%
Withdrawn %2.13%2.77%
Cert-withdrawn %0.00%2.25%
Rank#5
Active yearsFY2021–FY2025FY2020–FY2025
Worksite stateCANJ

Outcomes — NIVAGEN PHARMACEUTICALS, INC.

DOL case-status mix.

Certified97.9%
Withdrawn2.1%

Outcomes — Ernst & Young U.S. LLP

DOL case-status mix.

Certified94.9%
Cert-withdrawn2.3%
Withdrawn2.8%
Denied0.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

NIVAGEN PHARMACEUTICALS, INC.
Ernst & Young U.S. LLP

Top 5 occupations — NIVAGEN PHARMACEUTICALS, INC.

Top 5 occupations — Ernst & Young U.S. LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.